Brief: Blackrock Inc's Long Position In Wuxi Biologics Increases To 5.43% On Oct 10, HKEX Filing Shows
Oct 15 (Reuters) - BLACKROCK INC'S LONG POSITION IN WUXI BIOLOGICS 2269.HK INCREASES TO 5.43% ON OCT 10 FROM 4.92% - HKEX Further company coverage: 2269.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln